Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy
Study limitation reported by the research below: “Patient age and sex are not explicitly stated in the provided abstract; pediatric age group inferred from the condition (hepatoblastoma is predominantly a pediatric tumor).”